Ventilator, Continuous, Facility Use
Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.
OpenFDA device adverse-event casebook.
FDA Class II (moderate risk, special controls required), regulated under 21 CFR §868.5895 (Anesthesiology panel).
FDA MAUDE casebook
openFDA event book Ventilator, Continuous, Facility Use HEAVY-BOOK · MAUDE
#20 of 1000 · 212,024 reports · 1991–2026
- BOOK 212,024 reports
- RANK #20 of 1000
- DEATH 2,253 death-typed
- INJ 14,388 injury-typed
- MALF 194,497 malfunction
- SPAN 1991–2026
- PEAK 2023: 24,928
- PHOTO Drug Eluting Permanen…
Nearest event-volume peer: Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (16,070 report gap)
Ventilator, Continuous, Facility Use sits #20 of 1000 among tracked device types with 212,024 MAUDE reports spanning 1991–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →
Malfunction reports run above the device-type norm
Ventilator, Continuous, Facility Use carries 91.7% MALFUNCTION-coded reports, 26.9pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.
- DEATH 1.1% corpus 1.5% · near corpus mean (-0.4 pp)
- INJ 6.8% corpus 30.3% · below corpus mean (-23.5 pp)
- MALF 91.7% corpus 64.8% · above corpus mean (+26.9 pp)
Lead product-problem code Device Displays Incorrect Message is 12% of coded problems · Lead manufacturer RESPIRONICS, INC. accounts for 25% of manufacturer-tagged reports · Top event location is 57% of location-tagged rows .
Ventilator, Continuous, Facility Use in the event-volume neighbourhood
FDA MAUDE report totals among this device type and nearest nationwide peers
- Prosthesis
Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled
229,178 reports
- Drug Eluting…
Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes
228,094 reports
- Ventilator (this)
Ventilator, Continuous, Facility Use
212,024 reports
- Mesh
Mesh, Surgical, Polymeric
170,120 reports
- Staple
Staple, Implantable
169,612 reports
- Defibrillator
Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)
169,573 reports
What this shows Ventilator, Continuous, Facility Use carries 212,024 MAUDE reports, ranked #20 of 1000.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Top Product Problems
Yearly Trend
Reports fell to 14,199 in 2025, down from an average of 22,632 in the two years before.
Related Entities for Ventilator, Continuous, Facility Use
Top Manufacturers
Event Locations
Nationwide devices with a comparable volume-and-death footprint
Two openFDA-derived peer sets for Ventilator, Continuous, Facility Use: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.
Similar report volume
Nearest other device types by FDA MAUDE report count (212,024 here).
Similar death-typed counts
Nearest other device types by death-typed report count (2,253 here), distinct from the volume row.
Read our methodology - how this data is sourced, computed, and verified.
Disclaimer: MAUDE figures for Ventilator, Continuous, Facility Use are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.
Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Ventilator, Continuous, Facility Use; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.